HK1044536A1 - Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics - Google Patents

Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics

Info

Publication number
HK1044536A1
HK1044536A1 HK02106108A HK02106108A HK1044536A1 HK 1044536 A1 HK1044536 A1 HK 1044536A1 HK 02106108 A HK02106108 A HK 02106108A HK 02106108 A HK02106108 A HK 02106108A HK 1044536 A1 HK1044536 A1 HK 1044536A1
Authority
HK
Hong Kong
Prior art keywords
antidiabetics
crystals
acid derivative
oxyiminoalkanoic acid
oxyiminoalkanoic
Prior art date
Application number
HK02106108A
Other languages
English (en)
Inventor
Yu Momose
Hiroshi Imoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of HK1044536A1 publication Critical patent/HK1044536A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02106108A 1999-10-29 2002-08-21 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics HK1044536A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30834699 1999-10-29
PCT/JP2000/007482 WO2001032637A1 (en) 1999-10-29 2000-10-26 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics

Publications (1)

Publication Number Publication Date
HK1044536A1 true HK1044536A1 (en) 2002-10-25

Family

ID=17979966

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106108A HK1044536A1 (en) 1999-10-29 2002-08-21 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics

Country Status (19)

Country Link
US (1) US6777435B1 (xx)
EP (1) EP1224178B1 (xx)
KR (1) KR100433885B1 (xx)
CN (1) CN1407975A (xx)
AR (1) AR031078A1 (xx)
AT (1) ATE243684T1 (xx)
AU (1) AU7958100A (xx)
CA (1) CA2388200A1 (xx)
CL (1) CL2000002938A1 (xx)
CO (1) CO5261530A1 (xx)
DE (1) DE60003577T2 (xx)
HK (1) HK1044536A1 (xx)
HU (1) HUP0203884A3 (xx)
MY (1) MY135840A (xx)
NO (1) NO20022007L (xx)
PE (1) PE20010761A1 (xx)
PL (1) PL364171A1 (xx)
TW (1) TW558554B (xx)
WO (1) WO2001032637A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403903A1 (en) * 2000-03-28 2002-09-26 Masatoshi Hazama Angiogenesis inhibitors
WO2002080936A1 (en) 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
CA2443325C (en) * 2001-04-04 2011-06-14 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
US7217697B2 (en) 2001-05-30 2007-05-15 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor
TWI327462B (en) * 2002-01-18 2010-07-21 Sumitomo Chemical Co Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
CA2489145A1 (en) 2002-05-24 2003-12-04 Takeda Pharmaceutical Company Limited Insulin-sensitizing agent
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
AU2005289808B2 (en) * 2004-09-24 2011-11-03 The Government Of The United States As Represented By The Secretary Of The Army, U.S. Army Medical Research Institute Of Chemical Defense Method of treating organophosphorous poisoning
US20090181887A1 (en) * 2005-09-08 2009-07-16 Gastrotech Pharma A/S Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort
TW201138843A (en) 2009-12-18 2011-11-16 Colgate Palmolive Co Biguanide preservation of precipitated calcium carbonate
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
CA2937107C (en) * 2014-01-17 2020-12-22 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
KR102281228B1 (ko) 2019-09-03 2021-07-22 신창수 과수나무의 가지지지용 파이프클램프

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139470A0 (en) * 1998-05-11 2001-11-25 Takeda Chemical Industries Ltd Oxyiminoalkanoic acid derivatives
CA2389208A1 (en) * 1999-10-29 2001-05-10 Takeda Chemical Industries, Ltd. Process for the preparation of oxyiminoalkanoic acid derivatives

Also Published As

Publication number Publication date
CL2000002938A1 (es) 2009-05-15
MY135840A (en) 2008-07-31
CO5261530A1 (es) 2003-03-31
DE60003577T2 (de) 2004-04-29
PE20010761A1 (es) 2001-08-01
WO2001032637A1 (en) 2001-05-10
HUP0203884A2 (hu) 2003-03-28
NO20022007L (no) 2002-06-24
AU7958100A (en) 2001-05-14
KR20010102429A (ko) 2001-11-15
AR031078A1 (es) 2003-09-10
TW558554B (en) 2003-10-21
ATE243684T1 (de) 2003-07-15
EP1224178B1 (en) 2003-06-25
CN1407975A (zh) 2003-04-02
CA2388200A1 (en) 2001-05-21
PL364171A1 (en) 2004-12-13
KR100433885B1 (ko) 2004-06-04
HUP0203884A3 (en) 2005-01-28
DE60003577D1 (de) 2003-07-31
NO20022007D0 (no) 2002-04-26
EP1224178A1 (en) 2002-07-24
US6777435B1 (en) 2004-08-17

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
HK1048247A1 (en) Stable carotene-xanthophyll beadlet compositions and methods of use
IL154031A0 (en) Substituted sulfonylaminomethylbenzoic acid derivatives and preparation
HUP0200898A2 (en) Derivatives of venlafaxine and methods of preparing and using the same
EP1227821A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD FOR USE THEREOF
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HK1044536A1 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
ZA957187B (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments
PL339486A1 (en) Novel compounds - substituted 3-amino-3-aryl 1-propanols and method of obtaining them as well as therapeutic agent and method of obtaining same
EP1154997A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
HK1045260B (zh) 15-羥基二十碳四烯酸雜原子阻斷類似物及其使用方法
GB0111594D0 (en) Pipecolnic acid derivatives method of manufacturing the same and therapeutic agents containing these compounds
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU3356000A (en) L-arginine based formulations for treating diseases and methods of using same
AU6866700A (en) Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
PL345038A1 (en) Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
PL339487A1 (en) Novel compounds - substituted 3-amino-3-aryl 1-propanols and method of obtaining them as well as therapeutic agent and method of obtaining same
AU1101301A (en) 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
AU4116500A (en) The use of alpha lipoic acid in the antimetastatic treatment
ZA200105830B (en) Crystal polymorhism of aminoethylphenoxyacetic acid and derivative.
AU4101900A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
AU3673300A (en) N-substituted-n'-substituted urea derivative and use thereof as tnf-alpha production inhibitor
AU3702099A (en) The use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20071026